| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ankyrin binding | 4.78e-06 | 23 | 29 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.73e-05 | 227 | 29 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.59e-05 | 130 | 29 | 4 | GO:0005200 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 1.25e-04 | 1099 | 29 | 8 | GO:0008092 | |
| GeneOntologyMolecularFunction | MAP-kinase scaffold activity | 1.57e-04 | 13 | 29 | 2 | GO:0005078 | |
| GeneOntologyMolecularFunction | JUN kinase binding | 2.73e-04 | 17 | 29 | 2 | GO:0008432 | |
| GeneOntologyMolecularFunction | actin binding | 5.74e-04 | 479 | 29 | 5 | GO:0003779 | |
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 6.48e-04 | 26 | 29 | 2 | GO:0070530 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.11e-03 | 34 | 29 | 2 | GO:0030507 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 2.78e-03 | 54 | 29 | 2 | GO:0030159 | |
| GeneOntologyMolecularFunction | kinesin binding | 2.88e-03 | 55 | 29 | 2 | GO:0019894 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 3.31e-03 | 59 | 29 | 2 | GO:0031593 | |
| GeneOntologyBiologicalProcess | actin filament capping | 3.27e-05 | 46 | 28 | 3 | GO:0051693 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 4.74e-05 | 52 | 28 | 3 | GO:0030835 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 5.60e-05 | 156 | 28 | 4 | GO:0030833 | |
| GeneOntologyBiologicalProcess | NADP metabolic process | 5.92e-05 | 56 | 28 | 3 | GO:0006739 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 7.65e-05 | 61 | 28 | 3 | GO:0030834 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 9.14e-05 | 177 | 28 | 4 | GO:0008064 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 9.68e-05 | 66 | 28 | 3 | GO:0030042 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 9.75e-05 | 180 | 28 | 4 | GO:0030832 | |
| GeneOntologyBiologicalProcess | actin filament polymerization | 1.20e-04 | 190 | 28 | 4 | GO:0030041 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 1.42e-04 | 75 | 28 | 3 | GO:0030837 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 2.18e-04 | 222 | 28 | 4 | GO:0008154 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 2.35e-04 | 89 | 28 | 3 | GO:1901880 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 2.51e-04 | 91 | 28 | 3 | GO:0032272 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 2.54e-04 | 231 | 28 | 4 | GO:0032271 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 3.32e-04 | 100 | 28 | 3 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 3.83e-04 | 105 | 28 | 3 | GO:1901879 | |
| GeneOntologyBiologicalProcess | pentose-phosphate shunt | 4.04e-04 | 22 | 28 | 2 | GO:0006098 | |
| GeneOntologyBiologicalProcess | cell maturation | 4.40e-04 | 267 | 28 | 4 | GO:0048469 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | 4.59e-04 | 489 | 28 | 5 | GO:0043254 | |
| GeneOntologyBiologicalProcess | NADPH regeneration | 5.23e-04 | 25 | 28 | 2 | GO:0006740 | |
| GeneOntologyBiologicalProcess | actin filament organization | 5.51e-04 | 509 | 28 | 5 | GO:0007015 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | 6.17e-04 | 803 | 28 | 6 | GO:0030036 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 6.82e-04 | 300 | 28 | 4 | GO:0110053 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 7.43e-04 | 307 | 28 | 4 | GO:0018105 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 8.57e-04 | 319 | 28 | 4 | GO:0018209 | |
| GeneOntologyBiologicalProcess | glucose 6-phosphate metabolic process | 8.60e-04 | 32 | 28 | 2 | GO:0051156 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 9.61e-04 | 144 | 28 | 3 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 9.61e-04 | 144 | 28 | 3 | GO:0043244 | |
| GeneOntologyBiologicalProcess | protein polymerization | 1.02e-03 | 334 | 28 | 4 | GO:0051258 | |
| GeneOntologyBiologicalProcess | actin filament-based process | 1.20e-03 | 912 | 28 | 6 | GO:0030029 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 1.26e-03 | 354 | 28 | 4 | GO:0071695 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 1.33e-03 | 619 | 28 | 5 | GO:0006163 | |
| GeneOntologyCellularComponent | spectrin | 2.01e-07 | 9 | 29 | 3 | GO:0008091 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 6.65e-05 | 9 | 29 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | main axon | 2.52e-04 | 89 | 29 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 2.86e-04 | 93 | 29 | 3 | GO:0030864 | |
| GeneOntologyCellularComponent | axolemma | 3.84e-04 | 21 | 29 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | PML body | 6.81e-04 | 125 | 29 | 3 | GO:0016605 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 7.46e-04 | 129 | 29 | 3 | GO:0030863 | |
| GeneOntologyCellularComponent | M band | 8.43e-04 | 31 | 29 | 2 | GO:0031430 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.07e-03 | 576 | 29 | 5 | GO:0015629 | |
| GeneOntologyCellularComponent | cell cortex | 1.63e-03 | 371 | 29 | 4 | GO:0005938 | |
| GeneOntologyCellularComponent | A band | 2.36e-03 | 52 | 29 | 2 | GO:0031672 | |
| Domain | Spectrin_bsu | 1.21e-08 | 4 | 28 | 3 | IPR016343 | |
| Domain | JIP_LZII | 2.17e-06 | 2 | 28 | 2 | IPR032486 | |
| Domain | JIP_LZII | 2.17e-06 | 2 | 28 | 2 | PF16471 | |
| Domain | Actinin_actin-bd_CS | 5.24e-06 | 23 | 28 | 3 | IPR001589 | |
| Domain | ACTININ_2 | 5.24e-06 | 23 | 28 | 3 | PS00020 | |
| Domain | ACTININ_1 | 5.24e-06 | 23 | 28 | 3 | PS00019 | |
| Domain | Spectrin | 5.24e-06 | 23 | 28 | 3 | PF00435 | |
| Domain | Spectrin_repeat | 1.07e-05 | 29 | 28 | 3 | IPR002017 | |
| Domain | Jnk-SapK_ap_N | 1.30e-05 | 4 | 28 | 2 | PF09744 | |
| Domain | JNK/Rab-associated_protein-1_N | 1.30e-05 | 4 | 28 | 2 | IPR019143 | |
| Domain | Spectrin/alpha-actinin | 1.45e-05 | 32 | 28 | 3 | IPR018159 | |
| Domain | SPEC | 1.45e-05 | 32 | 28 | 3 | SM00150 | |
| Domain | RH2 | 2.16e-05 | 5 | 28 | 2 | PS51777 | |
| Domain | RH1 | 2.16e-05 | 5 | 28 | 2 | PS51776 | |
| Domain | PH_dom-spectrin-type | 7.75e-05 | 9 | 28 | 2 | IPR001605 | |
| Domain | CH | 1.24e-04 | 65 | 28 | 3 | SM00033 | |
| Domain | CH | 1.54e-04 | 70 | 28 | 3 | PF00307 | |
| Domain | - | 1.61e-04 | 71 | 28 | 3 | 1.10.418.10 | |
| Domain | CH | 1.75e-04 | 73 | 28 | 3 | PS50021 | |
| Domain | CH-domain | 1.90e-04 | 75 | 28 | 3 | IPR001715 | |
| Domain | - | 2.34e-03 | 48 | 28 | 2 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 3.06e-03 | 55 | 28 | 2 | IPR015915 | |
| Domain | Gal_Oxase/kelch_b-propeller | 3.52e-03 | 59 | 28 | 2 | IPR011043 | |
| Domain | Kelch_1 | 4.91e-03 | 70 | 28 | 2 | PF01344 | |
| Domain | Kelch_1 | 4.91e-03 | 70 | 28 | 2 | IPR006652 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.52e-07 | 10 | 23 | 3 | MM15112 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.66e-05 | 31 | 23 | 3 | M877 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.08e-05 | 38 | 23 | 3 | MM14969 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.41e-04 | 63 | 23 | 3 | M11187 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.77e-04 | 68 | 23 | 3 | MM14968 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 5.86e-04 | 102 | 23 | 3 | M27648 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 7.31e-04 | 110 | 23 | 3 | MM15350 | |
| Pubmed | 2.77e-10 | 13 | 29 | 4 | 18796539 | ||
| Pubmed | 5.21e-10 | 3 | 29 | 3 | 11294830 | ||
| Pubmed | β spectrin-dependent and domain specific mechanisms for Na+ channel clustering. | 5.21e-10 | 3 | 29 | 3 | 32425157 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 8.56e-08 | 11 | 29 | 3 | 17607528 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 4.22e-07 | 18 | 29 | 3 | 12119179 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 31690808 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 33788575 | ||
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.18e-06 | 25 | 29 | 3 | 8493579 | |
| Pubmed | 1.56e-06 | 1431 | 29 | 9 | 37142655 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 29328863 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 20493856 | ||
| Pubmed | JSAP1/JIP3 and JLP regulate kinesin-1-dependent axonal transport to prevent neuronal degeneration. | 2.01e-06 | 3 | 29 | 2 | 25571974 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 8479293 | ||
| Pubmed | JSAP1 and JLP are required for ARF6 localization to the midbody in cytokinesis. | 2.01e-06 | 3 | 29 | 2 | 25130574 | |
| Pubmed | Nodal β spectrins are required to maintain Na+ channel clustering and axon integrity. | 2.01e-06 | 3 | 29 | 2 | 32052742 | |
| Pubmed | Developmental expression of brain beta-spectrin isoform messenger RNAs. | 2.01e-06 | 3 | 29 | 2 | 1467942 | |
| Pubmed | Critical role of JSAP1 and JLP in axonal transport in the cerebellar Purkinje cells of mice. | 2.01e-06 | 3 | 29 | 2 | 26320416 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 6234993 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 4.02e-06 | 4 | 29 | 2 | 3862089 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 21412925 | ||
| Pubmed | Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein. | 4.02e-06 | 4 | 29 | 2 | 11106729 | |
| Pubmed | The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. | 4.02e-06 | 4 | 29 | 2 | 27624942 | |
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 4.02e-06 | 4 | 29 | 2 | 12820899 | |
| Pubmed | IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. | 6.70e-06 | 5 | 29 | 2 | 21464307 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 23142783 | ||
| Pubmed | LRRK2 and the stress response: interaction with MKKs and JNK-interacting proteins. | 1.00e-05 | 6 | 29 | 2 | 20173330 | |
| Pubmed | Fgf8 genetic labeling reveals the early specification of vestibular hair cell type in mouse utricle. | 1.87e-05 | 8 | 29 | 2 | 33046506 | |
| Pubmed | 2.12e-05 | 197 | 29 | 4 | 36604605 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 3.01e-05 | 10 | 29 | 2 | 22159418 | |
| Pubmed | 3.01e-05 | 10 | 29 | 2 | 34732824 | ||
| Pubmed | Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers. | 8.00e-05 | 16 | 29 | 2 | 21745462 | |
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 18723693 | ||
| Pubmed | A quantitative survey of gravity receptor function in mutant mouse strains. | 1.26e-04 | 20 | 29 | 2 | 16235133 | |
| Pubmed | 1.26e-04 | 20 | 29 | 2 | 12897243 | ||
| Pubmed | 1.26e-04 | 312 | 29 | 4 | 37120454 | ||
| Pubmed | 1.53e-04 | 22 | 29 | 2 | 15767678 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 1.64e-04 | 1016 | 29 | 6 | 19056867 | |
| Pubmed | 1.69e-04 | 638 | 29 | 5 | 33239621 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 1.80e-04 | 647 | 29 | 5 | 26618866 | |
| Pubmed | 1.88e-04 | 653 | 29 | 5 | 22586326 | ||
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 3.32e-04 | 162 | 29 | 3 | 14743216 | |
| Pubmed | Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions. | 4.23e-04 | 176 | 29 | 3 | 18614564 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 4.51e-04 | 180 | 29 | 3 | 30110629 | |
| Pubmed | 5.13e-04 | 40 | 29 | 2 | 28386764 | ||
| Pubmed | 5.75e-04 | 1285 | 29 | 6 | 35914814 | ||
| Pubmed | 7.03e-04 | 1335 | 29 | 6 | 29229926 | ||
| Pubmed | 7.15e-04 | 493 | 29 | 4 | 15368895 | ||
| Pubmed | 7.28e-04 | 878 | 29 | 5 | 37223481 | ||
| Pubmed | 7.37e-04 | 497 | 29 | 4 | 23414517 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.37e-04 | 497 | 29 | 4 | 36774506 | |
| Pubmed | 8.29e-04 | 513 | 29 | 4 | 25798074 | ||
| Interaction | ANK3 interactions | 9.18e-06 | 201 | 29 | 5 | int:ANK3 | |
| Interaction | KCTD13 interactions | CUL5 SPTBN4 ACTR3B SPRTN MYO7A MARK1 NDUFS1 SPTB SPTBN1 MAPK8IP3 | 1.44e-05 | 1394 | 29 | 10 | int:KCTD13 |
| Cytoband | 1q32.1 | 2.14e-03 | 108 | 29 | 2 | 1q32.1 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.41e-08 | 7 | 17 | 3 | 1113 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.81e-04 | 206 | 17 | 3 | 682 | |
| GeneFamily | Ankyrin repeat domain containing | 2.13e-02 | 242 | 17 | 2 | 403 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.20e-06 | 186 | 29 | 4 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.73e-05 | 138 | 29 | 3 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-04 | 156 | 29 | 3 | 5b2781d38a83b4b0f8a53cf321ce5db3a07d0818 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-04 | 156 | 29 | 3 | e0aef6104be16b12304b8e30358f444c1660e92f | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.51e-04 | 160 | 29 | 3 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-04 | 163 | 29 | 3 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.86e-04 | 172 | 29 | 3 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.90e-04 | 173 | 29 | 3 | 3a39c7f290a9914fcf747e6bc6f13a509413b33c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.93e-04 | 174 | 29 | 3 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.03e-04 | 177 | 29 | 3 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-04 | 177 | 29 | 3 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | 10x5'-GI_large-bowel-Mast-Mast_cells|GI_large-bowel / Manually curated celltypes from each tissue | 2.06e-04 | 178 | 29 | 3 | 8fc5f735afa25ae43c2acb1c710ade6e9e093e3c | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Mast_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-04 | 178 | 29 | 3 | c6704fcd21a9d2fe45679a1d998f04213b3bf224 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-04 | 178 | 29 | 3 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 10x5'-GI_large-bowel-Mast|GI_large-bowel / Manually curated celltypes from each tissue | 2.06e-04 | 178 | 29 | 3 | d10ed2543c96e1a2373f847e0b82144771e26d07 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-04 | 180 | 29 | 3 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 182 | 29 | 3 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 184 | 29 | 3 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-04 | 184 | 29 | 3 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 184 | 29 | 3 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 184 | 29 | 3 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | COPD-Lymphoid-B|COPD / Disease state, Lineage and Cell class | 2.31e-04 | 185 | 29 | 3 | 925e79c35c381dd44ec5fb921dca09ce43140135 | |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.31e-04 | 185 | 29 | 3 | 3dd5d2237ab50b13a41c12f85e1b79cd72ea567b | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 185 | 29 | 3 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.31e-04 | 185 | 29 | 3 | c91e1081e630a61c18f6af6d198bfcf296746852 | |
| ToppCell | COPD-Lymphoid-B|World / Disease state, Lineage and Cell class | 2.31e-04 | 185 | 29 | 3 | 22891ed75e25ef30dfa541cb82d85e08ce07e7d9 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 186 | 29 | 3 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.38e-04 | 187 | 29 | 3 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 29 | 3 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 190 | 29 | 3 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.50e-04 | 190 | 29 | 3 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.54e-04 | 191 | 29 | 3 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-04 | 192 | 29 | 3 | 60a02e0ccdc8c7af9bc875b248467304fe0d24a4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.58e-04 | 192 | 29 | 3 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-04 | 192 | 29 | 3 | 5532ea1bc012eb9303197b87e90bc39619b5ee2a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-04 | 192 | 29 | 3 | b223fca73e16668f69a78cf4457e349d01792540 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-04 | 192 | 29 | 3 | b5615a780b0ba24a8e554fac9238d3f0bcba52bc | |
| ToppCell | distal-Hematologic-Basophil/Mast_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-04 | 193 | 29 | 3 | f22d0a2ea6bbdd625909ccb6a89aca89ab670306 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.62e-04 | 193 | 29 | 3 | 360079cbaa18b74e4a48c5de40844faca076e1a6 | |
| ToppCell | distal-Hematologic-Basophil/Mast_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-04 | 193 | 29 | 3 | dcdc1498726c68bf590bf84cb81e5f7fb7ba4d78 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-04 | 193 | 29 | 3 | c17e87c042ef095ac99fdd6facf3bc2886924dc4 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-basophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.66e-04 | 194 | 29 | 3 | aca009b9f1f320c0a65ea16df6595d7ede0b1fda | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-04 | 195 | 29 | 3 | 9231e929657542b78a6480d44402866511129c7f | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.82e-04 | 198 | 29 | 3 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-04 | 199 | 29 | 3 | 2649afa3ccda78e9d1df26127b66cbfa0c6cd01d | |
| Drug | ADPribulose | 5.27e-07 | 13 | 29 | 3 | CID000197570 | |
| Drug | dimyristoylphosphatidylcholine | 1.28e-06 | 64 | 29 | 4 | CID000026197 | |
| Drug | MAPS | 3.98e-06 | 191 | 29 | 5 | CID000066161 | |
| Drug | dimethyl adipimidate | 7.37e-06 | 30 | 29 | 3 | CID000025738 | |
| Drug | AC1L9K72 | 2.99e-05 | 290 | 29 | 5 | CID000446872 | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 3.09e-05 | 48 | 29 | 3 | CID000092266 | |
| Drug | tetrathionate | 3.29e-05 | 49 | 29 | 3 | CID000026259 | |
| Drug | 1,1'-azobis(N,N-dimethylformamide | 6.59e-05 | 173 | 29 | 4 | CID000004278 | |
| Drug | AC1LA5D9 | 1.03e-04 | 12 | 29 | 2 | CID000462065 | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.03e-04 | 194 | 29 | 4 | 6178_DN | |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.05e-04 | 195 | 29 | 4 | 2359_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 29 | 4 | 5833_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.09e-04 | 197 | 29 | 4 | 6455_DN | |
| Drug | Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.11e-04 | 198 | 29 | 4 | 7163_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 199 | 29 | 4 | 3202_UP | |
| Drug | ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 1.13e-04 | 199 | 29 | 4 | 918_DN | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 1.16e-04 | 200 | 29 | 4 | 1654_DN | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 3.41e-09 | 4 | 29 | 3 | DOID:0050882 (implicated_via_orthology) | |
| Disease | radius bone mineral density | 5.13e-04 | 34 | 29 | 2 | EFO_0007933 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DNVEEMDWMVGRILD | 321 | P51690 | |
| MDWMVGRILDTLDVE | 326 | P51690 | |
| EIEENMVEWLREVGM | 471 | Q93034 | |
| GIIEDWDLMERFMEQ | 81 | Q9P1U1 | |
| LQEWLDELEEMMLVV | 336 | P01008 | |
| RLMELQEAVRWTEMI | 521 | O60271 | |
| EAVEMMDQIVHWVQE | 156 | P51606 | |
| RLMELQEAVRWTEMI | 541 | Q9UPT6 | |
| QELMFRGLHWVMEVL | 436 | Q14164 | |
| LMEWAENVMQIHADR | 2141 | Q9ULT8 | |
| VEMQGDEMTRIIWEL | 11 | O75874 | |
| MSVLWLEHDRETRMQ | 241 | Q9P2G3 | |
| MEMILKAEEGNHEWI | 261 | Q9P2S6 | |
| MKDRWMNVGHEEEEL | 306 | Q9P0L2 | |
| LDLHRMEAWKALVEM | 466 | Q8TBB5 | |
| WVDELFIIIMDMLQD | 816 | P42345 | |
| MLTEVMEVWHGLVIA | 1 | Q6ZWK4 | |
| WMHEILDMILNDGDV | 61 | Q6IMI6 | |
| MRILPRMHEDINEEW | 271 | P28331 | |
| VHDLMEDIEIMLWRN | 501 | Q7Z443 | |
| VHMLVQWMADLGLEV | 331 | Q9UHJ6 | |
| PWQEIHKLEVLMEEM | 931 | Q8NHU6 | |
| RDLMLWMEDVIRQIE | 1921 | Q01082 | |
| AEVEAWLGEQELLMM | 1631 | Q9H254 | |
| NEMWADLLELIDTRM | 1776 | P11277 | |
| MDDDLMLALRLQEEW | 1 | Q9H040 | |
| EAEDLKMLIRHMEHW | 96 | Q9BVW5 | |
| NIDSLIEHMIMLWID | 91 | P0DTE5 | |
| MVILQQGDHVWMDLR | 1 | Q13402 | |
| IQQMMEDKLAWERHT | 131 | P54296 |